Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

Structural basis for neutralization of Plasmodium vivax by naturally acquired human antibodies that target DBP.

Urusova D, Carias L, Huang Y, Nicolete VC, Popovici J, Roesch C, Salinas ND, Witkowski B, Ferreira MU, Adams JH, Gross ML, King CL, Tolia NH.

Nat Microbiol. 2019 May 27. doi: 10.1038/s41564-019-0461-2. [Epub ahead of print]

PMID:
31133752
2.

Identification and Characterization of Functional Human Monoclonal Antibodies to Plasmodium vivax Duffy-Binding Protein.

Carias LL, Dechavanne S, Nicolete VC, Sreng S, Suon S, Amaratunga C, Fairhurst RM, Dechavanne C, Barnes S, Witkowski B, Popovici J, Roesch C, Chen E, Ferreira MU, Tolia NH, Adams JH, King CL.

J Immunol. 2019 May 1;202(9):2648-2660. doi: 10.4049/jimmunol.1801631. Epub 2019 Apr 3.

PMID:
30944159
3.

Lysyl-tRNA synthetase as a drug target in malaria and cryptosporidiosis.

Baragaña B, Forte B, Choi R, Nakazawa Hewitt S, Bueren-Calabuig JA, Pisco JP, Peet C, Dranow DM, Robinson DA, Jansen C, Norcross NR, Vinayak S, Anderson M, Brooks CF, Cooper CA, Damerow S, Delves M, Dowers K, Duffy J, Edwards TE, Hallyburton I, Horst BG, Hulverson MA, Ferguson L, Jiménez-Díaz MB, Jumani RS, Lorimer DD, Love MS, Maher S, Matthews H, McNamara CW, Miller P, O'Neill S, Ojo KK, Osuna-Cabello M, Pinto E, Post J, Riley J, Rottmann M, Sanz LM, Scullion P, Sharma A, Shepherd SM, Shishikura Y, Simeons FRC, Stebbins EE, Stojanovski L, Straschil U, Tamaki FK, Tamjar J, Torrie LS, Vantaux A, Witkowski B, Wittlin S, Yogavel M, Zuccotto F, Angulo-Barturen I, Sinden R, Baum J, Gamo FJ, Mäser P, Kyle DE, Winzeler EA, Myler PJ, Wyatt PG, Floyd D, Matthews D, Sharma A, Striepen B, Huston CD, Gray DW, Fairlamb AH, Pisliakov AV, Walpole C, Read KD, Van Voorhis WC, Gilbert IH.

Proc Natl Acad Sci U S A. 2019 Apr 2;116(14):7015-7020. doi: 10.1073/pnas.1814685116. Epub 2019 Mar 20.

4.

Surgical management of the grade C pancreatic fistula after pancreatoduodenectomy.

Wroński M, Cebulski W, Witkowski B, Guzel T, Karkocha D, Lech G, Słodkowski M.

HPB (Oxford). 2019 Feb 15. pii: S1365-182X(19)30060-7. doi: 10.1016/j.hpb.2019.01.006. [Epub ahead of print]

PMID:
30777699
5.

Growth and optical properties of ZnO/Zn1-xMgxO quantum wells on ZnO microrods.

Pieniążek A, Teisseyre H, Jarosz D, Suffczyński J, Witkowski BS, Kret S, Boćkowski M, Reszka A, Godlewski M, Kozanecki A, Kowalski BJ.

Nanoscale. 2019 Jan 31;11(5):2275-2281. doi: 10.1039/c8nr07065b.

PMID:
30657512
6.

Efficacy and Safety of Pyronaridine-Artesunate plus Single-Dose Primaquine for Treatment of Uncomplicated Plasmodium falciparum Malaria in Eastern Cambodia.

Leang R, Mairet-Khedim M, Chea H, Huy R, Khim N, Mey Bouth D, Dorina Bustos M, Ringwald P, Witkowski B.

Antimicrob Agents Chemother. 2019 Feb 26;63(3). pii: e02242-18. doi: 10.1128/AAC.02242-18. Print 2019 Mar.

PMID:
30602520
7.

High performance and low temperature coal mine gas sensor activated by UV-irradiation.

Kimiagar S, Najafi V, Witkowski B, Pietruszka R, Godlewski M.

Sci Rep. 2018 Nov 2;8(1):16298. doi: 10.1038/s41598-018-34707-x.

8.

Kinetics of Limonene Secondary Organic Aerosol Oxidation in the Aqueous Phase.

Witkowski B, Al-Sharafi M, Gierczak T.

Environ Sci Technol. 2018 Oct 16;52(20):11583-11590. doi: 10.1021/acs.est.8b02516. Epub 2018 Sep 26.

PMID:
30207709
9.

Emerging Southeast Asian PfCRT mutations confer Plasmodium falciparum resistance to the first-line antimalarial piperaquine.

Ross LS, Dhingra SK, Mok S, Yeo T, Wicht KJ, Kümpornsin K, Takala-Harrison S, Witkowski B, Fairhurst RM, Ariey F, Menard D, Fidock DA.

Nat Commun. 2018 Aug 17;9(1):3314. doi: 10.1038/s41467-018-05652-0.

10.

Author Correction: A comprehensive model for assessment of liver stage therapies targeting Plasmodium vivax and Plasmodium falciparum.

Roth A, Maher SP, Conway AJ, Ubalee R, Chaumeau V, Andolina C, Kaba SA, Vantaux A, Bakowski MA, Thomson-Luque R, Adapa SR, Singh N, Barnes SJ, Cooper CA, Rouillier M, McNamara CW, Mikolajczak SA, Sather N, Witkowski B, Campo B, Kappe SHI, Lanar DE, Nosten F, Davidson S, Jiang RHY, Kyle DE, Adams JH.

Nat Commun. 2018 Jun 8;9(1):2317. doi: 10.1038/s41467-018-04817-1.

11.

A comprehensive model for assessment of liver stage therapies targeting Plasmodium vivax and Plasmodium falciparum.

Roth A, Maher SP, Conway AJ, Ubalee R, Chaumeau V, Andolina C, Kaba SA, Vantaux A, Bakowski MA, Thomson-Luque R, Adapa SR, Singh N, Barnes SJ, Cooper CA, Rouillier M, McNamara CW, Mikolajczak SA, Sather N, Witkowski B, Campo B, Kappe SHI, Lanar DE, Nosten F, Davidson S, Jiang RHY, Kyle DE, Adams JH.

Nat Commun. 2018 May 9;9(1):1837. doi: 10.1038/s41467-018-04221-9. Erratum in: Nat Commun. 2018 Jun 8;9(1):2317.

12.

Limononic Acid Oxidation by Hydroxyl Radicals and Ozone in the Aqueous Phase.

Witkowski B, Jurdana S, Gierczak T.

Environ Sci Technol. 2018 Mar 20;52(6):3402-3411. doi: 10.1021/acs.est.7b04867. Epub 2018 Feb 27.

PMID:
29444406
13.

Endoperoxide-based compounds: cross-resistance with artemisinins and selection of a Plasmodium falciparum lineage with a K13 non-synonymous polymorphism.

Paloque L, Witkowski B, Lelièvre J, Ouji M, Ben Haddou T, Ariey F, Robert A, Augereau JM, Ménard D, Meunier B, Benoit-Vical F.

J Antimicrob Chemother. 2018 Feb 1;73(2):395-403. doi: 10.1093/jac/dkx412.

PMID:
29177421
14.

Identification of proteins, drying oils, waxes and resins in the works of art micro-samples by chromatographic and mass spectrometric techniques.

Witkowski B, Duchnowicz A, Ganeczko M, Laudy A, Gierczak T, Biesaga M.

J Sep Sci. 2018 Feb;41(3):630-638. doi: 10.1002/jssc.201700937. Epub 2017 Dec 14.

PMID:
29150927
15.

cis-Pinonic Acid Oxidation by Hydroxyl Radicals in the Aqueous Phase under Acidic and Basic Conditions: Kinetics and Mechanism.

Witkowski B, Gierczak T.

Environ Sci Technol. 2017 Sep 5;51(17):9765-9773. doi: 10.1021/acs.est.7b02427. Epub 2017 Aug 10.

PMID:
28719200
16.

Abundant Acceptor Emission from Nitrogen-Doped ZnO Films Prepared by Atomic Layer Deposition under Oxygen-Rich Conditions.

Guziewicz E, Przezdziecka E, Snigurenko D, Jarosz D, Witkowski BS, Dluzewski P, Paszkowicz W.

ACS Appl Mater Interfaces. 2017 Aug 9;9(31):26143-26150. doi: 10.1021/acsami.7b04127. Epub 2017 Jul 27.

PMID:
28707878
17.

Comparison between minimally invasive and open surgical treatment in necrotizing pancreatitis.

Wroński M, Cebulski W, Witkowski B, Jankowski M, Kluciński A, Krasnodębski IW, Słodkowski M.

J Surg Res. 2017 Apr;210:22-31. doi: 10.1016/j.jss.2016.10.022. Epub 2016 Nov 2.

PMID:
28457332
18.

Plasmodium falciparum Resistance to Artemisinin Derivatives and Piperaquine: A Major Challenge for Malaria Elimination in Cambodia.

Duru V, Witkowski B, Ménard D.

Am J Trop Med Hyg. 2016 Dec 7;95(6):1228-1238. Epub 2016 Oct 17. Review.

19.

Biodegradation of the ZnO:Eu nanoparticles in the tissues of adult mouse after alimentary application.

Kielbik P, Kaszewski J, Rosowska J, Wolska E, Witkowski BS, Gralak MA, Gajewski Z, Godlewski M, Godlewski MM.

Nanomedicine. 2017 Apr;13(3):843-852. doi: 10.1016/j.nano.2016.11.002. Epub 2016 Nov 21.

PMID:
27884640
20.

A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype-genotype association study.

Witkowski B, Duru V, Khim N, Ross LS, Saintpierre B, Beghain J, Chy S, Kim S, Ke S, Kloeung N, Eam R, Khean C, Ken M, Loch K, Bouillon A, Domergue A, Ma L, Bouchier C, Leang R, Huy R, Nuel G, Barale JC, Legrand E, Ringwald P, Fidock DA, Mercereau-Puijalon O, Ariey F, Ménard D.

Lancet Infect Dis. 2017 Feb;17(2):174-183. doi: 10.1016/S1473-3099(16)30415-7. Epub 2016 Nov 3. Erratum in: Lancet Infect Dis. 2018 Aug;18(8):829.

21.

Optimal health and disease management using spatial uncertainty: a geographic characterization of emergent artemisinin-resistant Plasmodium falciparum distributions in Southeast Asia.

Grist EP, Flegg JA, Humphreys G, Mas IS, Anderson TJ, Ashley EA, Day NP, Dhorda M, Dondorp AM, Faiz MA, Gething PW, Hien TT, Hlaing TM, Imwong M, Kindermans JM, Maude RJ, Mayxay M, McDew-White M, Menard D, Nair S, Nosten F, Newton PN, Price RN, Pukrittayakamee S, Takala-Harrison S, Smithuis F, Nguyen NT, Tun KM, White NJ, Witkowski B, Woodrow CJ, Fairhurst RM, Sibley CH, Guerin PJ.

Int J Health Geogr. 2016 Oct 24;15(1):37.

22.

Artemisinin-Resistant Plasmodium falciparum K13 Mutant Alleles, Thailand-Myanmar Border.

Boullé M, Witkowski B, Duru V, Sriprawat K, Nair SK, McDew-White M, Anderson TJ, Phyo AP, Menard D, Nosten F.

Emerg Infect Dis. 2016 Aug;22(8):1503-5. doi: 10.3201/eid2208.160004. No abstract available.

23.

A Worldwide Map of Plasmodium falciparum K13-Propeller Polymorphisms.

Ménard D, Khim N, Beghain J, Adegnika AA, Shafiul-Alam M, Amodu O, Rahim-Awab G, Barnadas C, Berry A, Boum Y, Bustos MD, Cao J, Chen JH, Collet L, Cui L, Thakur GD, Dieye A, Djallé D, Dorkenoo MA, Eboumbou-Moukoko CE, Espino FE, Fandeur T, Ferreira-da-Cruz MF, Fola AA, Fuehrer HP, Hassan AM, Herrera S, Hongvanthong B, Houzé S, Ibrahim ML, Jahirul-Karim M, Jiang L, Kano S, Ali-Khan W, Khanthavong M, Kremsner PG, Lacerda M, Leang R, Leelawong M, Li M, Lin K, Mazarati JB, Ménard S, Morlais I, Muhindo-Mavoko H, Musset L, Na-Bangchang K, Nambozi M, Niaré K, Noedl H, Ouédraogo JB, Pillai DR, Pradines B, Quang-Phuc B, Ramharter M, Randrianarivelojosia M, Sattabongkot J, Sheikh-Omar A, Silué KD, Sirima SB, Sutherland C, Syafruddin D, Tahar R, Tang LH, Touré OA, Tshibangu-wa-Tshibangu P, Vigan-Womas I, Warsame M, Wini L, Zakeri S, Kim S, Eam R, Berne L, Khean C, Chy S, Ken M, Loch K, Canier L, Duru V, Legrand E, Barale JC, Stokes B, Straimer J, Witkowski B, Fidock DA, Rogier C, Ringwald P, Ariey F, Mercereau-Puijalon O; KARMA Consortium.

N Engl J Med. 2016 Jun 23;374(25):2453-64. doi: 10.1056/NEJMoa1513137.

24.

[Multiple and successive treatment failures in a patient infected by Plasmodium falciparum in Cambodia and treated by dihydroartemisinin-piperaquine].

Witkowski B, Khim N, Kim S, Domergue A, Duru V, Menard D.

Bull Soc Pathol Exot. 2016 May;109(2):87-90. doi: 10.1007/s13149-016-0487-4. Epub 2016 Apr 6. French.

PMID:
27100863
25.

Plasmodium copy number variation scan: gene copy numbers evaluation in haploid genomes.

Beghain J, Langlois AC, Legrand E, Grange L, Khim N, Witkowski B, Duru V, Ma L, Bouchier C, Ménard D, Paul RE, Ariey F.

Malar J. 2016 Apr 12;15:206. doi: 10.1186/s12936-016-1258-x.

26.

Plasmodium falciparum dihydroartemisinin-piperaquine failures in Cambodia are associated with mutant K13 parasites presenting high survival rates in novel piperaquine in vitro assays: retrospective and prospective investigations.

Duru V, Khim N, Leang R, Kim S, Domergue A, Kloeung N, Ke S, Chy S, Eam R, Khean C, Loch K, Ken M, Lek D, Beghain J, Ariey F, Guerin PJ, Huy R, Mercereau-Puijalon O, Witkowski B, Menard D.

BMC Med. 2015 Dec 22;13:305. doi: 10.1186/s12916-015-0539-5.

27.

Paramagnetism of cobalt-doped ZnO nanoparticles obtained by microwave solvothermal synthesis.

Wojnarowicz J, Kusnieruk S, Chudoba T, Gierlotka S, Lojkowski W, Knoff W, Lukasiewicz MI, Witkowski BS, Wolska A, Klepka MT, Story T, Godlewski M.

Beilstein J Nanotechnol. 2015 Sep 30;6:1957-69. doi: 10.3762/bjnano.6.200. eCollection 2015.

28.

Induction of Multidrug Tolerance in Plasmodium falciparum by Extended Artemisinin Pressure.

Ménard S, Ben Haddou T, Ramadani AP, Ariey F, Iriart X, Beghain J, Bouchier C, Witkowski B, Berry A, Mercereau-Puijalon O, Benoit-Vical F.

Emerg Infect Dis. 2015 Oct;21(10):1733-41. doi: 10.3201/eid2110.150682.

29.

Use of Plasmodium falciparum culture-adapted field isolates for in vitro exflagellation-blocking assay.

Leba LJ, Musset L, Pelleau S, Estevez Y, Birer C, Briolant S, Witkowski B, Ménard D, Delves MJ, Legrand E, Duplais C, Popovici J.

Malar J. 2015 Jun 4;14:234. doi: 10.1186/s12936-015-0752-x.

30.

Evidence of Plasmodium falciparum Malaria Multidrug Resistance to Artemisinin and Piperaquine in Western Cambodia: Dihydroartemisinin-Piperaquine Open-Label Multicenter Clinical Assessment.

Leang R, Taylor WR, Bouth DM, Song L, Tarning J, Char MC, Kim S, Witkowski B, Duru V, Domergue A, Khim N, Ringwald P, Menard D.

Antimicrob Agents Chemother. 2015 Aug;59(8):4719-26. doi: 10.1128/AAC.00835-15. Epub 2015 May 26.

31.

Low-Temperature Cathodoluminescence Investigations of High-Quality Zinc Oxide Nanorods.

Witkowski BS, Wachnicki L, Gieraltowska S, Reszka A, Kowalski BJ, Godlewski M.

Microsc Microanal. 2015 Jun;21(3):564-9. doi: 10.1017/S1431927615000264. Epub 2015 Apr 8.

PMID:
25850809
32.

Drug resistance. K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates.

Straimer J, Gnädig NF, Witkowski B, Amaratunga C, Duru V, Ramadani AP, Dacheux M, Khim N, Zhang L, Lam S, Gregory PD, Urnov FD, Mercereau-Puijalon O, Benoit-Vical F, Fairhurst RM, Ménard D, Fidock DA.

Science. 2015 Jan 23;347(6220):428-31. doi: 10.1126/science.1260867. Epub 2014 Dec 11.

33.

Histone methyltransferase inhibitors are orally bioavailable, fast-acting molecules with activity against different species causing malaria in humans.

Malmquist NA, Sundriyal S, Caron J, Chen P, Witkowski B, Menard D, Suwanarusk R, Renia L, Nosten F, Jiménez-Díaz MB, Angulo-Barturen I, Santos Martínez M, Ferrer S, Sanz LM, Gamo FJ, Wittlin S, Duffy S, Avery VM, Ruecker A, Delves MJ, Sinden RE, Fuchter MJ, Scherf A.

Antimicrob Agents Chemother. 2015 Feb;59(2):950-9. doi: 10.1128/AAC.04419-14. Epub 2014 Nov 24.

34.

[Towards a better understanding of the molecular mechanisms of P. falciparum resistance to artemisinin].

Khim N, Witkowski B, Duru V, Ariey F, Mercereau-Puijalon O, Ménard D.

Med Sci (Paris). 2014 Aug-Sep;30(8-9):727-9. doi: 10.1051/medsci/20143008004. Epub 2014 Sep 1. French. No abstract available.

35.

Plasmodium falciparum founder populations in western Cambodia have reduced artemisinin sensitivity in vitro.

Amaratunga C, Witkowski B, Dek D, Try V, Khim N, Miotto O, Ménard D, Fairhurst RM.

Antimicrob Agents Chemother. 2014 Aug;58(8):4935-7. doi: 10.1128/AAC.03055-14. Epub 2014 May 27.

36.

Artemisinin resistance in Plasmodium falciparum.

Amaratunga C, Witkowski B, Khim N, Menard D, Fairhurst RM.

Lancet Infect Dis. 2014 Jun;14(6):449-50. doi: 10.1016/S1473-3099(14)70777-7. No abstract available.

37.

Photovoltaic properties of ZnO nanorods/p-type Si heterojunction structures.

Pietruszka R, Witkowski BS, Luka G, Wachnicki L, Gieraltowska S, Kopalko K, Zielony E, Bieganski P, Placzek-Popko E, Godlewski M.

Beilstein J Nanotechnol. 2014 Feb 14;5:173-9. doi: 10.3762/bjnano.5.17. eCollection 2014.

38.

Global analysis of Plasmodium falciparum Na(+)/H(+) exchanger (pfnhe-1) allele polymorphism and its usefulness as a marker of in vitro resistance to quinine.

Ménard D, Andriantsoanirina V, Khim N, Ratsimbasoa A, Witkowski B, Benedet C, Canier L, Mercereau-Puijalon O, Durand R.

Int J Parasitol Drugs Drug Resist. 2012 Oct 26;3:8-19. doi: 10.1016/j.ijpddr.2012.10.001. eCollection 2013 Dec. Review.

39.

A molecular marker of artemisinin-resistant Plasmodium falciparum malaria.

Ariey F, Witkowski B, Amaratunga C, Beghain J, Langlois AC, Khim N, Kim S, Duru V, Bouchier C, Ma L, Lim P, Leang R, Duong S, Sreng S, Suon S, Chuor CM, Bout DM, Ménard S, Rogers WO, Genton B, Fandeur T, Miotto O, Ringwald P, Le Bras J, Berry A, Barale JC, Fairhurst RM, Benoit-Vical F, Mercereau-Puijalon O, Ménard D.

Nature. 2014 Jan 2;505(7481):50-5. doi: 10.1038/nature12876. Epub 2013 Dec 18.

40.

Whole genome sequencing of field isolates reveals a common duplication of the Duffy binding protein gene in Malagasy Plasmodium vivax strains.

Menard D, Chan ER, Benedet C, Ratsimbasoa A, Kim S, Chim P, Do C, Witkowski B, Durand R, Thellier M, Severini C, Legrand E, Musset L, Nour BY, Mercereau-Puijalon O, Serre D, Zimmerman PA.

PLoS Negl Trop Dis. 2013 Nov 21;7(11):e2489. doi: 10.1371/journal.pntd.0002489. eCollection 2013 Nov.

41.

Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: in-vitro and ex-vivo drug-response studies.

Witkowski B, Amaratunga C, Khim N, Sreng S, Chim P, Kim S, Lim P, Mao S, Sopha C, Sam B, Anderson JM, Duong S, Chuor CM, Taylor WR, Suon S, Mercereau-Puijalon O, Fairhurst RM, Menard D.

Lancet Infect Dis. 2013 Dec;13(12):1043-9. doi: 10.1016/S1473-3099(13)70252-4. Epub 2013 Sep 11.

42.

Correlation between Plasmodium yoelii nigeriensis susceptibility to artemisinin and alkylation of heme by the drug.

Robert A, Claparols C, Witkowski B, Benoit-Vical F.

Antimicrob Agents Chemother. 2013 Aug;57(8):3998-4000. doi: 10.1128/AAC.01064-13. Epub 2013 Jun 10.

43.

G6PD deficiency in Plasmodium falciparum and Plasmodium vivax malaria-infected Cambodian patients.

Khim N, Benedet C, Kim S, Kheng S, Siv S, Leang R, Lek S, Muth S, Chea N, Chuor CM, Duong S, Kerleguer A, Tor P, Chim P, Canier L, Witkowski B, Taylor WR, Ménard D.

Malar J. 2013 May 28;12:171. doi: 10.1186/1475-2875-12-171.

44.

Modification of Emission Properties of ZnO Layers due to Plasmonic Near-Field Coupling to Ag Nanoislands.

Papierska J, Witkowski BS, Derkachova A, Korona KP, Binder J, Gałkowski K, Wachnicki L, Godlewski M, Dietl T, Suffczyński J.

Plasmonics. 2013 Jun;8(2):913-919. Epub 2013 Feb 12.

45.

In Silico screening on the three-dimensional model of the Plasmodium vivax SUB1 protease leads to the validation of a novel anti-parasite compound.

Bouillon A, Giganti D, Benedet C, Gorgette O, Pêtres S, Crublet E, Girard-Blanc C, Witkowski B, Ménard D, Nilges M, Mercereau-Puijalon O, Stoven V, Barale JC.

J Biol Chem. 2013 Jun 21;288(25):18561-73. doi: 10.1074/jbc.M113.456764. Epub 2013 May 7.

46.

Analysis of α-acyloxyhydroperoxy aldehydes with electrospray ionization-tandem mass spectrometry (ESI-MS(n)).

Witkowski B, Gierczak T.

J Mass Spectrom. 2013 Jan;48(1):79-88. doi: 10.1002/jms.3130.

PMID:
23303750
47.

Plasmodium falciparum Na+/H+ exchanger (pfnhe-1) genetic polymorphism in Indian Ocean malaria-endemic areas.

Andriantsoanirina V, Khim N, Ratsimbasoa A, Witkowski B, Benedet C, Canier L, Bouchier C, Tichit M, Durand R, Ménard D.

Am J Trop Med Hyg. 2013 Jan;88(1):37-42. doi: 10.4269/ajtmh.2012.12-0359. Epub 2012 Dec 3.

48.

Reduced artemisinin susceptibility of Plasmodium falciparum ring stages in western Cambodia.

Witkowski B, Khim N, Chim P, Kim S, Ke S, Kloeung N, Chy S, Duong S, Leang R, Ringwald P, Dondorp AM, Tripura R, Benoit-Vical F, Berry A, Gorgette O, Ariey F, Barale JC, Mercereau-Puijalon O, Menard D.

Antimicrob Agents Chemother. 2013 Feb;57(2):914-23. doi: 10.1128/AAC.01868-12. Epub 2012 Dec 3.

49.

Focused Screening and Treatment (FSAT): a PCR-based strategy to detect malaria parasite carriers and contain drug resistant P. falciparum, Pailin, Cambodia.

Hoyer S, Nguon S, Kim S, Habib N, Khim N, Sum S, Christophel EM, Bjorge S, Thomson A, Kheng S, Chea N, Yok S, Top S, Ros S, Sophal U, Thompson MM, Mellor S, Ariey F, Witkowski B, Yeang C, Yeung S, Duong S, Newman RD, Menard D.

PLoS One. 2012;7(10):e45797. doi: 10.1371/journal.pone.0045797. Epub 2012 Oct 1.

50.

Implication of glutathione in the in vitro antiplasmodial mechanism of action of ellagic acid.

Njomnang Soh P, Witkowski B, Gales A, Huyghe E, Berry A, Pipy B, Benoit-Vical F.

PLoS One. 2012;7(9):e45906. doi: 10.1371/journal.pone.0045906. Epub 2012 Sep 28.

Supplemental Content

Loading ...
Support Center